Healthcare provider profile · identity verified

Rachael E. Vanden Langenberg, D.O.

Family Practice · GREEN BAY, WI · NPI 1003127465

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	672	176
Rosuvastatin Calcium	Rosuvastatin Calcium	541	148
Levothyroxine Sodium	Levothyroxine Sodium	484	95
Lisinopril	Lisinopril	471	120
Amlodipine Besylate	Amlodipine Besylate	362	85
Losartan Potassium	Losartan Potassium	349	91
Omeprazole	Omeprazole	298	71
Hydrochlorothiazide	Hydrochlorothiazide	257	67
Metoprolol Succinate	Metoprolol Succinate	226	56
Simvastatin	Simvastatin	224	59
Pantoprazole Sodium	Pantoprazole Sodium	222	61
Metformin Hcl	Metformin Hcl	215	54
Potassium Chloride	Potassium Chloride	197	45
Metformin Hcl Er	Metformin Hcl	193	51
Furosemide	Furosemide	188	49
Gabapentin	Gabapentin	181	28
Sertraline Hcl	Sertraline Hcl	173	42
Albuterol Sulfate Hfa	Albuterol Sulfate	172	68
Atenolol	Atenolol	136	34
Metoprolol Tartrate	Metoprolol Tartrate	134	39
Eliquis	Apixaban	123	22
Alendronate Sodium	Alendronate Sodium	122	30
Tamsulosin Hcl	Tamsulosin Hcl	102	27
Fluticasone Propionate	Fluticasone Propionate	100	33
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	100	25
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	97	27
Duloxetine Hcl	Duloxetine Hcl	96	23
Allopurinol	Allopurinol	92	20
Trazodone Hcl	Trazodone Hcl	92	25
Bupropion Xl	Bupropion Hcl	86	19
Ozempic	Semaglutide	78	18
Montelukast Sodium	Montelukast Sodium	77	18
Carvedilol	Carvedilol	75	20
Jardiance	Empagliflozin	71	19
Famotidine	Famotidine	69	20
Meloxicam	Meloxicam	64	25
Pravastatin Sodium	Pravastatin Sodium	64	16
Januvia	Sitagliptin Phosphate	63	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	62	13
Citalopram Hbr	Citalopram Hydrobromide	61	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	60	18
Diclofenac Sodium	Diclofenac Sodium	57	22
Donepezil Hcl	Donepezil Hcl	52	11
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Trulicity	Dulaglutide	47	suppressed
Aripiprazole	Aripiprazole	46	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	45	11
Xarelto	Rivaroxaban	45	suppressed
Tizanidine Hcl	Tizanidine Hcl	44	11
Buspirone Hcl	Buspirone Hcl	43	suppressed
Cephalexin	Cephalexin	40	24
Venlafaxine Hcl Er	Venlafaxine Hcl	40	suppressed
Warfarin Sodium	Warfarin Sodium	40	13
Lovastatin	Lovastatin	38	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	38	12
Glipizide Er	Glipizide	37	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	11
Clonidine Hcl	Clonidine Hcl	36	12
Enalapril Maleate	Enalapril Maleate	36	11
Nystatin	Nystatin	36	18
Triamcinolone Acetonide	Triamcinolone Acetonide	36	21
Spironolactone	Spironolactone	35	11
Escitalopram Oxalate	Escitalopram Oxalate	34	11
Ropinirole Hcl	Ropinirole Hcl	34	suppressed
Estradiol	Estradiol	33	13
Glipizide	Glipizide	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	33	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	33	11
Acyclovir	Acyclovir	32	11
Mirtazapine	Mirtazapine	32	suppressed
Hydralazine Hcl	Hydralazine Hcl	30	suppressed
Methylprednisolone	Methylprednisolone	29	26
Ondansetron Odt	Ondansetron	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Novolog Flexpen	Insulin Aspart	26	suppressed
Symbicort	Budesonide/Formoterol Fumarate	26	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Amoxicillin	Amoxicillin	25	15
Irbesartan	Irbesartan	25	suppressed
Celecoxib	Celecoxib	23	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Temazepam	Temazepam	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Valsartan	Valsartan	21	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Memantine Hcl	Memantine Hcl	20	suppressed
Azithromycin	Azithromycin	19	18
Hydroxyzine Pamoate	Hydroxyzine Pamoate	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Clonazepam	Clonazepam	18	suppressed
Ondansetron Hcl	Ondansetron Hcl	18	11
Propranolol Hcl	Propranolol Hcl	18	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	18	suppressed
Mounjaro	Tirzepatide	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	15
Lorazepam	Lorazepam	16	suppressed
Soliqua 100-33	Insulin Glargine/Lixisenatide	16	suppressed
Tramadol Hcl	Tramadol Hcl	16	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	15	suppressed
Glimepiride	Glimepiride	15	suppressed
Liothyronine Sodium	Liothyronine Sodium	15	suppressed
Naproxen	Naproxen	15	suppressed
Pregabalin	Pregabalin	15	suppressed
Verapamil Er	Verapamil Hcl	15	suppressed
Breo Ellipta	Fluticasone/Vilanterol	14	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Sodium Chloride	Sodium Chloride Irrig Solution	14	suppressed
Azathioprine	Azathioprine	13	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Nystop	Nystatin	13	suppressed
Scopolamine	Scopolamine	13	suppressed
Torsemide	Torsemide	13	suppressed
Amantadine	Amantadine Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Eszopiclone	Eszopiclone	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Klor-Con M10	Potassium Chloride	12	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Neurontin	Gabapentin	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Rizatriptan	Rizatriptan Benzoate	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error